Total planned funding: $203,856,289
Allocations
Countries/Regions
Ukraine | $203,856,289 |
Organizational Types
Unknown | $59,470,995 |
NGO | $44,004,709 |
Private Contractor | $36,243,894 |
Own Agency | $27,775,620 |
Multi-lateral Agency | $12,925,607 |
University | $10,677,000 |
Implementing Agency | $6,725,040 |
Other USG Agency | $4,183,424 |
Host Country Government Agency | $1,850,000 |
Program Areas
Governance and Systems | $87,266,371 |
Treatment | $36,646,118 |
Prevention | $22,535,891 |
Testing | $21,631,487 |
Management and Operations | $19,855,203 |
Care | $15,921,219 |
Budget Codes
OHSS: Health Systems Strengthening | $50,348,945 |
HTXS: Treatment: Adult Treatment | $24,082,123 |
HVSI: Strategic Information | $22,691,866 |
HVCT: Testing: HIV Testing and Counseling | $21,631,487 |
HVMS: Management and Operations | $19,855,203 |
HLAB: Laboratory Infrastructure | $14,225,560 |
HTXD: Treatment: ARV Drugs | $12,563,995 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $11,623,385 |
HVTB: Care: TB/HIV | $8,829,294 |
HVOP: Sexual Prevention: Other Sexual Prevention | $7,514,423 |
HBHC: Care: Adult Care and Support | $4,348,732 |
HKID: Care: Orphans and Vulnerable Children | $2,743,193 |
HMBL: Biomedical Prevention: Blood Safety | $2,687,636 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $293,357 |
HMIN: Biomedical Prevention: Injection Safety | $250,000 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $167,090 |
PDCS: Care: Pediatric Care and Support | $0 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $0 |
PDTX: Treatment: Pediatric Treatment | $0 |
Top Partner Programs
Not Available:
$55,700,995
Countries/Regions
USG Aggregated Agencies:
$21,821,297
Countries/Regions
Chemonics International:
$20,772,383
Countries/Regions
Deloitte Consulting Limited:
$10,671,511
Countries/Regions